Anti-KRAS G12D mutant (D113)

Anti-KRAS G12D mutant [D113], Recombinant, IgG1 kappa, Human
Artikelnummer
ABAAb03877-10.0
Verpackungseinheit
100 μg
Hersteller
Absolute Antibody

Verfügbarkeit: wird geladen...
Preis wird geladen...
CloneID: D113

Antigen Long Description: The original antibody was generated by immunizing mice with a synthetic dodecapeptide 'KLVVVGADGVGK'.

Buffer Composition: PBS with 0.02% Proclin 300.

Available Custom Conjugation Options: AP, HRP, Fluorescein, APC, PE, Biotin Type A, Biotin Type B, Streptavidin, FluoroProbes 647H, Atto488, APC/Cy7, PE/Cy7

Uniprot Accession No.: P01116-2

Specificity Statement: This antibody binds the G12D mutant form of human KRAS protein. This ras protein binds GDP/GTP and possess intrinsic GTPase activity, that results in conversion of nucleotide guanosine triphosphate (GTP) into guanosine diphosphate (GDP). This protein plays an important role in many signal transduction pathways and regulation of cell proliferation. Somatic KRAS mutations are highly observed in leukemias, colorectal cancer, pancreatic cancer and lung cancer. KRAS mutation is G12D which is estimated to be present in up to 37% pancreatic cancers and over 12% of colorectal cancers.

Application Notes (Clone): The binding reactivity and epitope characterization of this antibody towards human KRAS G12D mutant was determined using ELISA (PMID: 9440050). This antibody can bind both the peptide 'KLVVVGADGVGK' conjugated BSA as well as KRAS G12D mutant in an ELISA.
Mehr Informationen
Artikelnummer ABAAb03877-10.0
Hersteller Absolute Antibody
Hersteller Artikelnummer Ab03877-10.0
Verpackungseinheit 100 μg
Mengeneinheit STK
Reaktivität Human
Klonalität Recombinant
Methode ELISA
Isotyp IgG1 kappa
Wirt Human
Produktinformation (PDF) Download
MSDS (PDF) Download